登录 注册 会员服务 联系我们

The role of CD44 in the assessment of minimal residual disease of multiple myeloma by flow cytometry

  • Published:2021-10-02 Issue:4 Volume:14 Page:299-307
  • ISSN:1868-9256
  • Container-title:Journal of Hematopathology
  • language:en
  • Short-container-title:J Hematopathol

Author:

Zuo Xiaojia,Feng Jinyi,Ye Lilin,Xing Miao,Deng Zhikui,Gu Xuefeng,Liu Dingsheng

Funder

Discipline Construction Program of Pudong New District Health Bureau of Shanghai

Publisher

Springer Science and Business Media LLC

Subject

Hematology,Histology,Pathology and Forensic Medicine

Reference31 articles.

1. Naeimi Kararoudi M, Nagai Y, Elmas E, De Souza Fernandes Pereira M, Ali SA, Imus PH, Wethington D, Borrello IM, Lee DA, Ghiaur G (2020) CD38 deletion of human primary NK cells eliminates daratumumab-induced fratricide and boosts their effector activity [J]. Blood 136(21):2416–2427. https://doi.org/10.1182/blood.2020006200

2. Schavgoulidze A, Cazaubiel T, Perrot A, Avet-Loiseau H, Corre J (2021) Multiple myeloma: heterogeneous in every way [J]. Cancers (Basel) 13(6):1285. https://doi.org/10.3390/cancers13061285

3. Lopes R, Ferreira BV, Caetano J, Barahona F, Carneiro EA, João C (2021) Boosting immunity against multiple myeloma [J]. Cancers 13(6):1221. https://doi.org/10.3390/cancers13061221

4. O’steen S, Comstock ML, Orozco JJ, Hamlin DK, Wilbur DS, Jones JC, Kenoyer A, Nartea ME, Lin Y, Miller BW, Gooley TA, Tuazon SA, Till BG, Gopal AK, Sandmaier BM, Press OW, Green DJ (2019) The alpha-emitter astatine-211 targeted to CD38 can eradicate multiple myeloma in a disseminated disease model [J]. Blood 134(15):1247–1256. https://doi.org/10.1182/blood.2019001250

5. Lahuerta JJ, Paiva B, Vidriales MB, Cordon L, Cedena MT, Puig N, Martinez-Lopez J, Rosinol L, Gutierrez NC, Martin-Ramos ML, Oriol A, Teruel AI, Echeveste MA, De Paz R, De Arriba F, Hernandez MT, Palomera L, Martinez R, Martin A, Alegre A, De La Rubia J, Orfao A, Mateos MV, Blade J, San-Miguel JF, Group G P C S (2017) Depth of response in multiple myeloma: a pooled analysis of three pethema/gem clinical trials [J]. J Clin Oncol 35(25):2900–2910. https://doi.org/10.1200/JCO.2016.69.2517

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3